Onconova Therapeutics Inc. (ONTX) Hits New 12-Month Low at $3.01
Onconova Therapeutics Inc. (NASDAQ:ONTX)’s share price reached a new 52-week low during trading on Thursday . The stock traded as low as $3.01 and last traded at $3.10, with a volume of 159,966 shares. The stock had previously closed at $3.25.
Separately, Maxim Group set a $6.00 target price on Onconova Therapeutics and gave the stock a “buy” rating in a research report on Thursday, August 11th.
The stock’s market capitalization is $19.43 million. The stock has a 50 day moving average of $3.80 and a 200 day moving average of $4.68.
Onconova Therapeutics (NASDAQ:ONTX) last released its quarterly earnings results on Monday, August 15th. The biopharmaceutical company reported ($1.96) earnings per share for the quarter. The firm earned $2.25 million during the quarter. On average, equities research analysts forecast that Onconova Therapeutics Inc. will post ($2.15) EPS for the current year.
Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.